Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × sabatolimab × Clear all

Phase

Phase 1/2 2 Phase 3 1 Phase 2 1 Phase 1 1

Status

Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 145 Docetaxel 135 Carboplatin 132 Bevacizumab 132 pembrolizumab 128 Radiotherapy 122 Gemcitabine 121 Cisplatin 121 Paclitaxel 115 Capecitabine 106 Rituximab 102 Fluorouracil 96 Oxaliplatin 90 Nivolumab 80 Irinotecan 78 Leucovorin 76 Doxorubicin 74 Dexamethasone 71 Pemetrexed 68 fludarabine 65 fludarabine phosphate 62 Etoposide 61 Bortezomib 59 Erlotinib Hydrochloride 58 Cetuximab 54 Methotrexate 53 Cytarabine 52 Trastuzumab 49 Lenalidomide 45 Sorafenib 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04150029 2026-01-13

STIMULUS-AML1

Novartis

Phase 2 Terminated

90 enrolled 26 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡